These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2136721)

  • 21. Interactions between the renin-angiotensin system and the parasympathetic nervous system in heart failure.
    Osterziel KJ; Hänlein D; Dietz R
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S70-4. PubMed ID: 7898098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurohormonal systems during progression of heart failure: a review.
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Cardiology; 1993; 83(1-2):21-9. PubMed ID: 7903208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurohormonal mechanisms in congestive heart failure].
    Goch JH
    Pol Arch Med Wewn; 1992; 88(2-3):171-4. PubMed ID: 1492022
    [No Abstract]   [Full Text] [Related]  

  • 24. New neurohormonal antagonists and atrial natriuretic peptide in the treatment of congestive heart failure.
    Abraham WT
    Coron Artery Dis; 1994 Feb; 5(2):127-36. PubMed ID: 7910095
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurohormonal factors in heart failure. I].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 Apr; 49(4):239-52. PubMed ID: 8650399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure.
    van Zwieten PA
    Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurohormonal factors in congestive heart failure].
    Hannedouche T; Fournier JF
    Ann Med Interne (Paris); 1987; 138(2):123-9. PubMed ID: 3555207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic application of ANP: past and future].
    Saito Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():139-46. PubMed ID: 15506358
    [No Abstract]   [Full Text] [Related]  

  • 32. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroendocrine changes in chronic cardiac insufficiency].
    Jaeger P; Cohen-Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Arch Mal Coeur Vaiss; 1988 Feb; 81(2):157-62. PubMed ID: 2967069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial natriuretic factor in cardiovascular diseases].
    Nakamura M; Arakawa N; Hiramori K
    Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M; Tocci G; Pagannone E
    Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium retention in heart failure.
    Cannon PJ
    Cardiol Clin; 1989 Feb; 7(1):49-62. PubMed ID: 2523241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in renal function in experimental congestive heart failure.
    Awazu M; Ichikawa I
    Semin Nephrol; 1994 Sep; 14(5):401-11. PubMed ID: 7997647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.